These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9082464)

  • 21. Effects of opiates, opioid antagonists and cocaine on the endogenous opioid system: clinical and laboratory studies.
    Kreek MJ
    NIDA Res Monogr; 1992; 119():44-8. PubMed ID: 1435981
    [No Abstract]   [Full Text] [Related]  

  • 22. [The protective effect of opioid receptor antagonists on acute myocardial ischemia/reperfusion injury in rats].
    Zan XY; Li PJ; Zhang ZY; Tang XQ; Zhao JH; Cao W
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):693-4. PubMed ID: 17996143
    [No Abstract]   [Full Text] [Related]  

  • 23. Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities.
    Sadée W; Wang D; Bilsky EJ
    Life Sci; 2005 Feb; 76(13):1427-37. PubMed ID: 15680308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists.
    Fujii H; Watanabe A; Nemoto T; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem Lett; 2009 Jan; 19(2):438-41. PubMed ID: 19042127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
    Rady JJ; Elmer GI; Fujimoto JM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent developments in the study of opioid receptors.
    Cox BM
    Mol Pharmacol; 2013 Apr; 83(4):723-8. PubMed ID: 23249538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TIPP opioid peptide family: development of delta antagonists, delta agonists, and mixed mu agonist/delta antagonists.
    Schiller PW; Weltrowska G; Berezowska I; Nguyen TM; Wilkes BC; Lemieux C; Chung NN
    Biopolymers; 1999; 51(6):411-25. PubMed ID: 10797230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The agonist paradox: agonists and antagonists of acetylcholine receptors and opioid receptors.
    Dukhovich FS; Darkhovskii MB; Gorbatova EN; Polyakov VS
    Chem Biodivers; 2005 Mar; 2(3):354-66. PubMed ID: 17191984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The mechanism of the action of opiate receptor antagonists in acute shock-induced blood loss].
    Sherman DM; Lafarenko VA
    Eksp Klin Farmakol; 1998; 61(1):25-9. PubMed ID: 9575407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different receptor sites mediate opioid agonism and antagonism.
    Portoghese PS; Takemori AE
    J Med Chem; 1983 Oct; 26(10):1341-3. PubMed ID: 6312042
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA; Traynor JR
    Brain Res; 2006 Feb; 1073-1074():290-6. PubMed ID: 16443205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonists, inverse agonists, and protagonists.
    Shader RI
    J Clin Psychopharmacol; 2003 Aug; 23(4):321-2. PubMed ID: 12920405
    [No Abstract]   [Full Text] [Related]  

  • 33. Opioid receptor blockade reduces Fas-induced hepatitis in mice.
    Jaume M; Jacquet S; Cavaillès P; Macé G; Stephan L; Blanpied C; Demur C; Brousset P; Dietrich G
    Hepatology; 2004 Nov; 40(5):1136-43. PubMed ID: 15389866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One- and two-receptor models of opioid drug action.
    Gero A
    Life Sci; 1985 Mar; 36(11):1021-4. PubMed ID: 2983162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Highlights in opioid agonists and antagonists.
    Lauretti GR
    Expert Rev Neurother; 2006 Apr; 6(4):613-22. PubMed ID: 16623659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discriminative effects of narcotic agonists and antagonists in the rat and squirrel monkey [proceedings].
    Holtzman SG; Shannon E; Schaefer GJ
    Psychopharmacol Bull; 1977 Jan; 13(1):37-8. PubMed ID: 402009
    [No Abstract]   [Full Text] [Related]  

  • 37. A chimeric analysis of the opioid receptor domains critical for the binding selectivity of mu opioid ligands.
    Watson B; Meng F; Akil H
    Neurobiol Dis; 1996 Feb; 3(1):87-96. PubMed ID: 9173916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Na+ modulation, inverse agonism, and anorectic potency of 4-phenylpiperidine opioid antagonists.
    Emmerson PJ; McKinzie JH; Surface PL; Suter TM; Mitch CH; Statnick MA
    Eur J Pharmacol; 2004 Jun; 494(2-3):121-30. PubMed ID: 15212965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nonselective and selective opioid receptors antagonists on antinociceptive action of acetaminophen [part III].
    Bujalska M
    Pol J Pharmacol; 2004; 56(5):539-45. PubMed ID: 15591641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response of neuropeptide Y-induced feeding to mu-, delta- and kappa-opioid receptor antagonists in the neonatal chick.
    Dodo K; Izumi T; Ueda H; Bungo T
    Neurosci Lett; 2005 Jan; 373(2):85-8. PubMed ID: 15567558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.